MEDITERA TIBBI MALZEMEMEDITERA TIBBI MALZEMEMEDITERA TIBBI MALZEME

MEDITERA TIBBI MALZEME

No trades
See on Supercharts

MEDTR fundamentals

MEDITERA TIBBI MALZEME financial statements, including revenue, expenses, profit, and loss

The total revenue of MEDTR for the last quarter is 553.05 M TRY, and it's 49.44% higher compared to the previous quarter. The net income of Q3 24 is 18.39 M TRY.

Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: TRY
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth